Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 1—January 2022
CME ACTIVITY - Synopsis

Using the Acute Flaccid Paralysis Surveillance System to Identify Cases of Acute Flaccid Myelitis, Australia, 2000‒2018

Liz J. WalkerComments to Author , Bruce R. Thorley, Anne Morris, Elizabeth J. Elliott, Nathan Saul, Philip N. Britton, and on behalf of the Australian Polio Expert Panel1
Author affiliations: The Australian National University, Canberra, Australian Capital Territory, Australia (L.J. Walker); Australian Government Department of Health, Canberra (L.J. Walker, N. Saul); Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia (B.R. Thorley); The Children’s Hospital at Westmead, Sydney, New South Wales, Australia (A. Morris, E.J. Elliott, P.N. Britton); The University of Sydney, Sydney (E.J. Elliott, P.N. Britton)

Main Article

Table 1

Characteristics of cases of acute flaccid myleitis for 41 children <15 years of age, Australia, 2000‒2018*

Characteristic
Value
Sex
M 19 (46.3)
F
22 (53.7)
Median age, y, at onset (range)
4.07 (0.25–14.08)
Prodromal illness
Confirmed 6 (14.6)
Probable 15 (36.6)
No 13 (31.7)
Unknown
7 (17.1)
Confirmed specified
URTI 5 (83.3)
Gastrointestinal
1 (16.7)
Site of paralysis
Known 39 (95.1)
Unknown
2 (4.9)
Site of paralysis, upper limbs
Unilateral 11 (28.2)
Bilateral
3 (7.7)
Site of paralysis, lower limbs
Unilateral 3 (7.7)
Bilateral
13 (33.3)
Site of paralysis, upper and lower limbs
Unilateral 5 (12.8)
Bilateral
4 (10.3)
Bulbar/cranial nerve palsy
Yes 14 (34.1)
No 26 (63.4)
Unknown
1 (2.4)
Reduced sensation
Yes 6 (14.6)
No 34 (82.9)
Unknown
1 (2.4)
Bladder/bowel dysfunction
Yes 17 (41.5)
No 15 (36.5)
Unknown
9 (22.0)
Median CSF protein level, g/L (range)
0.43 (0.11–1.18)
Elevated CSF protein level >0.55 g/L
Yes 8 (19.5)
No 29 (70.7)
Unknown
4 (9.8)
Median CSF leukocyte count/mm3 (range)
38 (0–267)
Pleocytosis >5 cells mm3
Yes 33 (80.5)
No 3 (7.3)
Unknown 5 (12.2)

*Values are no. (%) unless otherwise indicated. CSF, cerebrospinal fluid; URTI, upper respiratory tract infection.

Main Article

1Members of this panel are listed at the end of this article.

Page created: October 08, 2021
Page updated: December 16, 2021
Page reviewed: December 16, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external